High-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer: long-term experience of Swedish single-center

por Johansson, Bengt, Olsén, Johan Staby, Karlsson, Leif, Lundin, Erik, Lennernäs, Bo
Publicado 2021

Predicting toxicity caused by high-dose-rate brachytherapy single boost for prostate cancer

por Olsén, Johan Staby, Estefan, Dalia, Valachis, Antonios, Jakobsson, Frida, Karlsson, Leif, Johansson, Bengt
Publicado 2022